Beutel J, Ziemssen F, Lüke M, Partsch M, Bartz-Schmidt KU, Bevacizumab Study Group, Gelisken F (2010) Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results. Int Ophthalmol 30: 15-22
Beutel J, Peters S, Lüke M, Aisenbrey S, Szurman P, Spitzer MS, Yoeruek E, the Bevacizumab Study Group and Salvatore Grisanti (2010) Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol 88: 103-109
Bruckmann A, Lüke J, Schiefer U (2010) A topodiagnostically characteristic visual field defect. Ophthalmologe 107: 1164-1168
Brüggemann A, Holl-Ulrich K, Müller M (2010) Klinische Aspekte der Arteriitis temporalis. Verlaufsvarianz bis zu letalen Komplikationen. Ophthalmologe 107: 930-936
Brüggemann A, Grisanti S (2010) Therapiemöglichkeiten der altersbedingten neovaskulären Makuladegeneration. Focus Uni Lübeck, 18-22
Brüggemann A, von Bülow M, Finas D, Bechrakis NE, Hoerauf H, Müller M (2010) Bilateral diffuse uveal melanocytic proliferation associated with the recurrence of Bartholin`s gland carcinoma. Br J Ophthalmol (epub)
Curcio CA, Johnson M, Rudolf R (2010) Thematic issue: Apolipoprotein B-containing lipoproteins in retinal aging and age-related maculopathy. J Lipid Res 51: 451-67
Deuter CM, Klink T, Müller M, Geerling G, Zierhut M (2010) Sekundärglaukom bei Uveitis. Ophthalmologe 107: 427-34
Eisenbeis C, Neppert B, Menke T, Pape S, Schrader S, Geerling G, Müller M (2010) Anatomic and subjective success of structured surgical treatment strategy in the management of chronic epiphora - a postoperative analysis of contentment. Klin Monatsbl Augenheilkd 227: 879-886
Garreis F, Schlorf T, Worlitzsch D, Steven P, Bräuer L, Jäger K, Paulsen FP (2010) Roles of human ß-defensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells. Histochem Cell Biol 134: 59-73
Gehlsen U, Hüttmann G, Steven P (2010) Intravital multidimensional real-time imaging of the conjunctival immune system. Dev Ophthalmol 45: 40-8
Geerling G, Müller M, Zierhut M, Klink T (2010) Glaukom und Keratoplastik. Ophthalmologe 107: 409-18
Grisanti S, Tura A (2010) Qualitätsunterschiede zwischen Ranibizumab Original und Fertigspritzen. Ophthalmologe 107: 1123-1132 (pdf)
Klink T, Müller M, Zierhut M, Geerling G (2010) Glaukom und Katarakt. Ophthalmologe 107: 403-8
Koeberle PD, Tura A, Tassew NG, Schlichter LC, Monnier PP (2010) The repulsive guidance molecule. RGMa, promotes retinal ganglion cell survival in vitro and in vivo. Neuroscience 169: 495-504
Lüke M, Januschowski K, Lüke J, Grisanti S, Szurman P, Dietz K, Kampik A, Bartz-Schmidt KU, Eibl-Lindner KH (2010) The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina. Graefes Arch Clin Ophthalmol 248: 511-518
Lüke J, Tatar O, Lüke M, Bartz-Schmidt KU, Grisanti S (2010) Papillary capillary activation in Terson syndrome. Int Ophthalmol 30: 439-441
Lüke M, Januschowski K, Tura A, Lüke J, Nassar K, Lüke C, Schneider T, Szurman P, Grisanti S, Bartz-Schmidt KU (2010) Effects of pegatanib sodium on retinal function in isolated perfused vertebrate retina. Curr Eye Res 35: 248-54
Lüke J, Nassar K, Lüke M, Tura A, Merz H, Giannis A, Grisanti S (2010) The effect of adjuvant dimethylenastron, a mitotic kinesin Eg5 inhibitor, in experimental glaucoma filtration surgery. Curr Eye Res 35: 1090-8
Margolina E, Torrent Despouy J, Grisanti S, Pape S, Ewert I, Neppert B, Müller M (2010) Schwere sekundäre Skleritis nach Pseudomonas aeruginosa bedingtem Hornhautulcus. Klin Monatsbl Augenheilkd 227: 987-9
Müller M, Schulz-Wackerbarth C, Steven P, Lankenau E, Bonin T, Müller H, Brüggemann A, Birngruber R, Grisanti S, Hüttmann G (2010) Slit-lamp-adapted fourier-domain OCT for anterior and posterior segments: Preliminary results and comparison to time-domain OCT. Curr Eye Res 35: 722-732
Müller M, Kohnen T (2010) Inzisionen für die biaxiale und koaxiale mikroinzisionale Kataraktchirurgie. Ophthalmologe 107: 108-115
Müller M, Geerling G, Zierhut M, Klink T (2010) Glaukom und Netzhautchirurgie. Ophthalmologe 107: 419-426
Müller M, Brüggemann A (2010) Kanaloplastik - eine interventionelle Glaukom-Operation. DGII-Aktuell 10: 3
Neppert B (2010) Impaired visual function. Dtsch Ärztebl Int 107: 709-10
Reinthal EK, Rohrbach JM, Grisanti S (2010) Glaukom-Drainagechirurgie. Klin Monatsbl Augenheilkd 227: 49-55
Rudolf M, Torrent Despouy J, Grisanti S (2010) Drusen - Indikatoren für eine AMD? Der Augenspiegel 5: 24-27
Sander T, Gottschalk S, Hertel S, Neppert B, Helmchen C (2010) MRI of the eye muscles in a case of ophthalmoplegia caused by common carotid artery occlusion suggests ischemic myopathy. J Neurol Sci Oct. 7
Siapich SA, Wrubel H, Albanna W, Alnawaiseh M, Hescheler J, Weiergräber M, Lüke M, Schneider T (2010) Effect of ZnCI2 and chelation of zinc ions by NN-diethyldithiocarbamate (DEDTC) on the ERG b-wave amplitude from the isolated superfused vertebrate retina. Curr Eye Res 35: 322-24
Siebelmann S, Steven P (2010) CALT - ein Epiphänomen? Trockenes Auge als Autoimmunerkrankung - Spezifischere Therapie durch Modulation. Ophthalmologische Nachrichten 12: 15
Sivaprasad S, Grisanti S (2010) Intravitreal pegatanib sodium for choroidal neovascularization secondary to age-related macular degeneration: Pan European Experience. Eye (Epub ahead of print)
Steven P (2010) Neuer Aspekt in der antientzündlichen Therapie des Trockenen Auges. Augenspiegel 04: 18-19
Steven P, Hovakimyan M, Guthoff RF, Hüttmann G, Stachs O (2010) Imaging corneal crosslinking by autofluorescence 2-photon microscopy, second harmonic generation, and fluorescence lifetime measurements. J Cataract Refract Surg 36: 2150-9
Thaler S, Grisanti S, Klingel K, Raible A, Kempf VA, Schulte B (2010) Intermediate uveitis and arthralgia as early symptoms in Whipple`s disease. Int J Infect Dis Suppl 3:e388-9
Thaler S, Fiedorowicz M, Choragiewicz TJ, Bolz S, Tura A, Henke-Fahle S, Yoeruek E, Zrenner E, Bartz-Schmidt KU, Ziemssen F, Schüttauf F (2010) Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegatanib in rats both with and without prior retinal ganglion cell damage. Acta Ophthalmol 88: e170-6